Accordingly, MSCs derived from ALL patients at diagnosis that produce endogenously high amounts of BMP4 exhibit low levels of proliferation that gradually increase during treatment in correlation with decreased BMP4 production. The gene discussed is BMP4; the disease is acute lymphoblastic leukemia.